cdmo.directory
← Compare landing

Cell-Easy vs Mytos Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cell-easy/mytos

CategoryCell-EasyMytos Inc.
Listed sitecdmocdmo
SummaryCell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.Automated CDMO for stem-cell derived and regenerative therapies, using its iDEM automated tissue production system to report about 40% lower cost per batch than manual methods. Offers Proof of Value pilots to test technical fit and ROI before scale-up.
Services
  • Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Cell-Line Development
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
Modalities
  • Cell Therapy
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Ophthalmology
Locations
  • Headquarters, Toulouse, Occitanie, France
  • London, London, England, United Kingdom
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.